10-(2,3,5,6,8,9,11,12,14,15-decahydrobenzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide | 1196879-10-3

10-(2,3,5,6,8,9,11,12,14,15-decahydrobenzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide is a complex and highly specialized compound belonging to the class of BODIPY (boron-dipyrromethene) derivatives. Its structure consists of a BODIPY core fused with a unique hexaoxacyclooctadecin ring, incorporating both fluorine and difluoro groups. This combination of structural elements results in enhanced chemical stability, fluorescence properties, and reactivity. The presence of multiple functional groups allows for versatility in various applications, especially in fields requiring advanced fluorescence and targeting capabilities.

One of the primary applications of this compound is in fluorescence-based imaging techniques. Due to its strong fluorescence and high photostability, this BODIPY derivative is an excellent candidate for use as a fluorescent probe in bioimaging. Its ability to target specific cells or tissues can be achieved through the modification of its chemical structure, making it an invaluable tool for tracking cellular processes and molecular interactions in live organisms. Researchers can use these compounds to visualize and study disease mechanisms, protein dynamics, and other cellular phenomena with high precision and reliability.

Another significant application is in chemical sensing and detection systems. The unique structure of the compound, particularly the presence of the difluoro and hexaoxacyclooctadecin groups, provides enhanced reactivity and sensitivity to specific chemical environments. These BODIPY derivatives can be functionalized to create highly selective sensors capable of detecting a wide range of analytes, including ions, small molecules, or even biomolecules. This feature makes them highly useful in analytical chemistry, environmental monitoring, and diagnostic tools, where accurate and real-time measurements are essential.

The compound also holds potential in energy conversion technologies, such as organic photovoltaic (OPV) cells and other solar energy applications. The BODIPY core's strong light absorption and electronic properties make it an ideal candidate for use in organic semiconductors. By integrating this compound into OPV devices, researchers aim to enhance light absorption, improve charge transport, and boost the overall efficiency of solar cells. The incorporation of this compound into the organic materials of solar cells can contribute to the development of more efficient, cost-effective energy conversion systems.

Finally, the compound is promising for use in photodynamic therapy (PDT), a technique that uses light to activate therapeutic agents for the treatment of cancers and other diseases. The unique combination of fluorine, difluoro, and hexaoxacyclooctadecin groups within this BODIPY derivative enhances its ability to generate reactive oxygen species (ROS) under light exposure. When conjugated to targeting molecules, it can specifically accumulate in tumor cells and, upon activation, release ROS to selectively destroy cancerous tissues. This makes it a potential candidate for targeted cancer therapies and other light-activated medical treatments.